[1]
Haroun, M.; Tratrat, C.; Kochkar, H.; Nair, A.B. Recent advances in the development of 1,2,3-triazole-containing derivatives as potential antifungal agents and inhibitors of lanosterol 14α-demethylase. Curr. Top. Med. Chem., 2021, 21(6), 462-506.
[2]
Sulimov, V.B.; Kutov, D.C.; Taschilova, A.S.; Ilin, I.S.; Tyrtyshnikov, E.E.; Sulimov, A.V. Docking paradigm in drug design. Curr. Top. Med. Chem., 2021, 21(6), 507-546.
[3]
Borah, P.; Deb, P.K.; Venugopala, K.N.; Al-Shar’i, N.A.; Singh, V.; Deka, S.; Srivastava, A.; Tiwari, V.; Mailavaram, R.P. Tuberculosis: An update on pathophysiology, molecular mechanisms of drug resistance, newer anti-tb drugs, treatment regimens and host-directed therapies. Curr. Top. Med. Chem., 2021, 21(6), 547-570.
Current Topics in Medicinal Chemistry
Title:Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part-IV
Volume: 21 Issue: 6
Author(s): Athina Geronikaki
Affiliation:
Export Options
About this article
Cite this article as:
Geronikaki Athina , Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part-IV, Current Topics in Medicinal Chemistry 2021; 21 (6) . https://dx.doi.org/10.2174/156802662106210304111713
DOI https://dx.doi.org/10.2174/156802662106210304111713 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
5
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements